|
Video: What is a Stock Split?
|
|
Clene is a clinical-stage pharmaceutical company focusing on the discovery, development, and commercialization of clean-surfaced nanotechnology therapeutics. Co. is focused on addressing the unmet medical needs in two areas: first, those related to central nervous system disorders including Amyotrophic Lateral Sclerosis, Multiple Sclerosis, and Parkinson's Disease; and second, those related to COVID-19, an infectious viral respiratory disease with serious and sometimes fatal co-morbidities. In addition to the development of clean-surfaced nanocrystals, Co.'s electro-crystal-chemistry platform can produce ionic solutions of various transition elements including silver, zinc, and others. According to our Clene stock split history records, Clene has had 0 splits. | |
|
Clene (CLNN) has 0 splits in our Clene stock split history database.
Looking at the Clene stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Clene shares, starting with a $10,000 purchase of CLNN, presented on a split-history-adjusted basis factoring in the complete Clene stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/19/2018 |
|
End date: |
05/03/2024 |
|
Start price/share: |
$9.75 |
|
End price/share: |
$0.43 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-95.59% |
|
Average Annual Total Return: |
-43.06% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$440.97 |
|
Years: |
5.54 |
|
|
|
|
|